Filing Details
- Accession Number:
- 0001181431-13-046111
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-22 16:18:57
- Reporting Period:
- 2013-08-21
- Filing Date:
- 2013-08-22
- Accepted Time:
- 2013-08-22 16:18:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1429260 | Coronado Biosciences Inc | CNDO | Pharmaceutical Preparations (2834) | 205157386 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1542419 | Lucy Lu | C/O Coronado Biosciences, Inc. 24 New England Executive Park Burlington MA 01803 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.001 | Acquisiton | 2013-08-21 | 5,000 | $7.38 | 24,524 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Options to purchase Common Stock | $6.85 | 2022-02-22 | 225,000 | 225,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2022-02-22 | 225,000 | 225,000 | Direct |
Footnotes
- One-third of the shares will vest on each of February 22, 2013, 2014 and 2015.